Science
Democrats Grill N.I.H. Leader on Cuts: Who Is Calling the Shots?
As the Trump administration clamped down on the country’s medical research funding apparatus in recent months, scientists and administrators at the National Institutes of Health often privately wondered how much autonomy the agency’s director, Dr. Jay Bhattacharya, had.
After all, the Department of Government Efficiency, Elon Musk’s signature cost-cutting project, helped drive decisions to cancel or delay research grants. Other projects fell victim to President Trump’s face-off with universities over antisemitism. But given an opportunity before a Senate panel on Tuesday to dispel suspicions about who wields influence at the N.I.H., Dr. Bhattacharya did little to claim ownership of perhaps the rockiest period in the agency’s many decades of funding research institutions.
Decisions to freeze grant payments to Northwestern University “happened before I got into office,” Dr. Bhattacharya told the panel, members of the Senate Appropriations Committee.
He repeatedly said a proposal to shrink the N.I.H. budget by $18 billion — nearly 40 percent — was “a collaboration between Congress and the administration” and declined to talk in detail about how the cuts would affect the agency.
And pressed on an effort to curtail funding to universities for research overhead expenses — a cost-cutting move that is baked into the administration’s 2026 budget proposal — Dr. Bhattacharya said, “I don’t want to get into that,” citing ongoing litigation.
Several Democrats on the committee said they were confused about who was pulling the strings at the agency.
“I want to know, who is withholding this funding?” demanded Senator Tammy Baldwin of Wisconsin, a Democrat, citing evidence that the N.I.H. had distributed billions of dollars less in grants so far this year than in the same period last year. “Is it you? Is it DOGE? Is it O.M.B.?” she added, referring to the Office of Management and Budget. “Who is making those decisions?”
Dr. Bhattacharya responded, “There’s a range of decisions, I think, that led to some of those pauses of grants.” He said, for example, that it had been his call to move away from what he called “politicized science,” a term he has used in the past to describe research related to diversity and equity issues. But he said that restrictions on research funding at Harvard and other leading institutions had been “joint with the administration.”
Senator Dick Durbin of Illinois, another Democrat, reacted sharply after Dr. Bhattacharya denied responsibility for the administration’s freezing research payments to Northwestern.
An email from an N.I.H. official in mid-April, weeks after Dr. Bhattacharya’s confirmation, directed employees not to issue grant awards to Northwestern and several other universities and not to tell the institutions why their funding had been frozen.
“The buck stops in your office,” Mr. Durbin told Dr. Bhattacharya. “Don’t blame another person.”
The Trump administration’s effort to significantly shrink the agency’s spending next year drew criticism from senators of both parties, including Senator Susan Collins of Maine, a Republican.
The proposed reduction “is so disturbing,” she told Dr. Bhattacharya. “It would delay or stop effective treatments and cures from being developed for diseases like Alzheimer’s, cancer, Type 1 diabetes.” The plans, she said, put the United States at risk of “falling behind China.”
Dr. Bhattacharya said that the N.I.H. was committed to research on Alzheimer’s and other diseases and that he would work with lawmakers to address “the health needs of all Americans.”
The director did open the door to an agreement between the Trump administration and leading universities that would unfreeze their medical research funding, although he offered no details about the prospects for such an agreement or what it would take to arrive at one. “I’m very hopeful that a resolution can be made with the universities where those grants have been paused,” he said.
The N.I.H. in recent months has abruptly ended more than 1,300 grant awards and delayed funding for more than 1,000 other projects. On Monday, scores of N.I.H. employees signed their names to a letter saying those actions had been undertaken on the basis of ideological preferences and without scientific staff input, effectively censoring research on issues like health disparities, Covid, the health effects of climate change and sexual health.
Dr. Bhattacharya said on Tuesday that he had set up a process for scientists to appeal funding cuts. The agency, he said, would vet appeals within weeks.
Science
Video: See the Moment the Artemis II Astronauts Exit the Orion Capsule
new video loaded: See the Moment the Artemis II Astronauts Exit the Orion Capsule
transcript
transcript
See the Moment the Artemis II Astronauts Exit the Orion Capsule
New video shows the moment the Orion capsule opened after landing last week. Inside were the Artemis II astronauts who had completed a 10-day mission around the moon.
-
“Yes!” “Yeah!” “Let’s go!” “Ike, welcome home. Christina, welcome home. Jeremy, welcome home, brother. There it is — Reid. What’s up? Welcome home, brother.” “Thank you.”
By Cynthia Silva
April 14, 2026
Science
‘Dr. Pimple Popper’ Sandra Lee had a stroke last fall. Here’s how the TV doc is bouncing back
Last fall, “Dr. Pimple Popper” suddenly became a patient herself.
Dr. Sandra Lee, the reality TV dermatologist and surgeon known for tackling ick-inducing skin situations on camera, had a bad day a week before Thanksgiving 2025 while she was taping new episodes of her show at her Upland office.
“I had what I thought was a hot flash. I got super sweaty and didn’t feel like myself,” she told People in an interview published Tuesday. She said she finished the shoot and then headed to her parents’ nearby home, where that evening she experienced shooting pains in one leg and later had trouble navigating down a flight of stairs in the middle of the night.
When she awakened the next day, she said, her left side wasn’t working properly and she was having trouble speaking clearly. It was definitely more than a hot flash.
Her doctor dad — also a dermatologist — told her to get herself to an ER, where she had an MRI that showed evidence of an ischemic stroke, where a vessel supplying blood to the brain gets obstructed. The diagnosis was a shock.
“As a physician I couldn’t deny that I had slurred speech, that I was having weakness on one side,” she said, “but I was like, ‘Well, this is a dream, right?’”
Lee, 55, said unmanaged cholesterol levels and high blood pressure were likely contributors to the stroke, plus the stress of balancing her real-life practice with the demands of “Dr. Pimple Popper.” She returned to production in January, she said, though she was more than a little freaked out.
“I don’t like that I don’t have total control of my left hand or the grip wasn’t as strong. If I feel like I’m not at my best — it’s very scary,” Lee said.
Her neurologist told the outlet that Lee’s symptoms are pretty much gone. Lee said she still notices slight differences when she speaks.
The TV doc is on blood thinners now and is still doing some physical therapy after spending two months post-stroke working through PT and occupational therapy. Lee had to make sure her left hand, among other body parts, was functional and that her balance and movement bounced back.
She does, after all, do precise procedures on camera for the Lifetime audience.
And with new episodes of “Dr. Pimple Popper” set to debut Monday for the first time since 2023, Lee remains fascinated by the people who spend time watching her do extractions and excisions, both on the show and online.
“People watch the videos over and over again because it helps them go to sleep at night,” she told People. But, she added, “Others watch it like it’s a scary movie or a roller coaster.”
Science
Trump administration promised ‘gold standard science.’ Scientists say they got fool’s gold
When President Trump announced Robert F. Kennedy Jr. as his pick for Health and Human Services secretary, he declared that the appointment marked the return of “Gold Standard Scientific Research” in the U.S.
In May 2025 Trump signed the “Restoring Gold Standard Science” executive order. Agencies including NASA and the Department of Energy filed reports on how their science met the official White House “gold standard.” Administration figures peppered public remarks, publications and social media posts with the phrase.
On paper, the administration’s nine-point definition for “gold standard science” reads like a list of fundamental research integrity principles that any scientist would endorse: science that is reproducible, transparent, forthcoming on error and uncertainty, collaborative, skeptical, built on falsifiable hypotheses, impartially peer reviewed, accepting of negative results and free of conflicts of interest.
In practice, critics say, the phrase has become shorthand for science in which preferred outcomes outweigh inconvenient evidence.
“This use of ‘gold standard science’ is deceptive. It sounds really good on its face. It’s advocating for things that are normative in the scientific community,” said Jules Barbati-Dajches, an analyst at the Union of Concerned Scientists, a nonprofit advocacy group.
The same executive order that turned the term into a policy rolled back all scientific integrity policies established during the Biden administration, Barbati-Dajches pointed out, making it harder to pursue and publish scientific findings without threat of political interference.
“It undercuts all of the values and standards and principles that were already being prioritized and implemented in federal agencies,” Barbati-Dajches said.
The executive order describes a decline in public trust in science that began during the COVID-19 pandemic. It cites examples in which government agencies “used or promoted scientific information in a highly misleading manner,” such as the Centers for Disease Control and Prevention’s school-reopening guidelines, a contentious count of the North Atlantic right whale population by the National Marine Fisheries Service and the use by several government agencies of an Intergovernmental Panel on Climate Change warming model that the executive order describes as “highly unlikely.”
“The Trump administration is ensuring that political agendas and ideologies never again corrupt policymaking that should be guided only by Gold Standard Science,” White House spokesman Kush Desai wrote in response to questions from The Times. “So-called ‘scientists’ who are only now concerned that politics are being prioritized over evidence after having stayed silent during the pandemic era are either delusional or partisan hacks.”
Credible, reliable and impartial evidence is the goal of legitimate science. But “the use of the term ‘gold standard science’ is being preferentially used based on the context,” said Dr. Daniel Jernigan, who resigned as director of the CDC’s National Center for Emerging and Zoonotic Infectious Diseases in August over concerns that its new leadership was not taking an “evidence-based approach to things,” he said at the time.
Jernigan cited Kennedy’s changes to the Advisory Committee on Immunization Practices, which advises the CDC on vaccinations. The committee had long followed a set of guidelines known as the Evidence to Recommendations framework, which establishes clear rules for how different types of evidence must be weighed and evaluated when making decisions.
Kennedy replaced the entire 17-member committee with a handpicked group heavily weighted toward vaccine skepticism. “Public trust has eroded,” Kennedy said at the time. “Only through radical transparency and gold standard science, will we earn it back.”
The reconstituted group largely abandoned the framework, allowing the committee to judge evidence of dubious quality alongside large randomized controlled trials.
Its first meeting included an error-filled presentation from a vaccine skeptic on the preservative thimerosal that focused only on a few reports of the shot harming individuals, but left out the many studies that have shown its safety across large populations. The committee ultimately voted not to recommend further vaccines containing thimerosal, which was already removed from childhood vaccines in 2001.
Meanwhile, Jernigan noted, National Institutes of Health director and acting CDC director Dr. Jay Bhattacharya has continued to delay the release of a study that found COVID-19 vaccines reduced hospitalizations related to the virus by 55%.
According to media reports, the study used hospital patients’ vaccination status to calculate the success of the season’s vaccine, a method long used to determine flu vaccine effectiveness. Bhattacharya reportedly wanted to wait for a randomized clinical trial — a method that scientists frequently cite as the “gold standard” for determining an intervention’s effectiveness, but one that is expensive and too time-consuming to evaluate the success of a seasonal flu or COVID-19 shot.
Accepting a lower standard of evidence for vaccines’ reported harms than for their apparent benefits “is not a good way to practice science: that your ideology, your decision about how things should be, determines what your evidence is,” Jernigan said.
The Trump administration didn’t coin the term “gold standard science,” which has been floating around for at least half a century as a label for top-quality research methods. Over the decades, critics have pointed out that it’s not as shiny a metaphor as it seems.
In finance, the gold standard fixes a currency’s value against a specific quantity of a specific object. But in science, nothing is fixed. Old conclusions and beliefs are constantly being overwritten as new evidence comes to light.
“Gold standard science in 1990 would be malpractice in some respects in 2026, and five years from now the gold standard may have changed again, because we’re constantly innovating,” said David Blumenthal, a professor at the Harvard School of Public Health and co-author of the book “Whiplash: From the Battle for Obamacare to the War on Science.”
“Science is changeable and the methods improve constantly, and the people who are most familiar with the possibilities and realities of those methods are the people doing the work at any given time,” he said. “And if they’re not involved, then it’s not gold standard.”
-
Atlanta, GA1 week ago1 teenage girl killed, another injured in shooting at Piedmont Park, police say
-
Georgia1 week agoGeorgia House Special Runoff Election 2026 Live Results
-
Arkansas4 days agoArkansas TV meteorologist Melinda Mayo retires after nearly four decades on air
-
Pennsylvania1 week agoParents charged after toddler injured by wolf at Pennsylvania zoo
-
Ohio14 hours ago‘Little Rascals’ star Bug Hall arrested in Ohio
-
Milwaukee, WI1 week agoPotawatomi Casino Hotel evacuated after fire breaks out in rooftop HVAC system
-
Austin, TX7 days agoABC Kite Fest Returns to Austin for Annual Celebration – Austin Today
-
World1 week agoZelenskyy warns US-Iran war could divert critical aid from Ukraine